72 Results for "

BMP-2

" in MedChemExpress (MCE) Product Catalog:
Products (72)

72 Results for "BMP-2" in MCE Product Catalog:

22
22 Publications Verification
Cat. No.: HY-P7007
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuBMP-4; BMP-2B
Species:  
Source:  
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-P7006
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuBMP-2; BMP2A; BMP-2A; BMP2
Species:  
Source:  
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-17408
CAS No.: 73573-88-3
Synonyms: Compactin; ML236B
Mevastatin (Compactin) is a first HMG-CoA reductase inhibitor that belongs to the statins class. Mevastatin is a lipid-lowering agent, and induces apoptosis, arrests cancer cells in G0/G1 phase. Mevastatin also increases endothelial nitric oxide synthase (eNOS) mRNA and protein levels. Mevastatin has antitumor activity and has the potential for cardiovascular diseases treatment [2] .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-126675A
CAS No.: 2241300-51-4
Pureté:  99.94%
Domaines de recherche:  

Inflammation/Immunology

AS2863619 is an orally active CDK8/19 inhibitor that also inhibits BMP2, MDA5 and RIG-I receptors. AS2863619 targets Stat5a-CDK8/19 to promote the differentiation of CD4 + T cells into regulatory T cells and induce FOXP3 expression, thereby restoring immune homeostasis and establishing transplant immune tolerance. AS2863619 also enhances the BMP2/SMAD signaling pathway to promote osteogenic differentiation and inhibit adipogenic differentiation. AS2863619 exerts osteoprotective effects by alleviating inflammation-induced impairment of osteogenic function and inducing neutrophil apoptosis (apoptosis). AS2863619 can be applied to research in related fields such as periodontitis-induced bone defects [2] .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-126675
CAS No.: 2241300-50-3
Pureté:  99.68%
Domaines de recherche:  

Inflammation/Immunology

AS2863619 free base is an orally active CDK8/19 inhibitor that also inhibits BMP2, MDA5 and RIG-I receptors. AS2863619 free base targets Stat5a-CDK8/19 to promote the differentiation of CD4 + T cells into regulatory T cells and induce FOXP3 expression, thereby restoring immune homeostasis and establishing transplant immune tolerance. AS2863619 free base also enhances the BMP2/SMAD signaling pathway to promote osteogenic differentiation and inhibit adipogenic differentiation. AS2863619 free base exerts osteoprotective effects by alleviating inflammation-induced impairment of osteogenic function and inducing neutrophil apoptosis (apoptosis). AS2863619 free base can be applied to research in related fields such as periodontitis-induced bone defects [2] .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P74379
Pureté:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: BMP-2B; BMP-4; Bone morphogenetic protein 4; DVR4
Species:  
Source:  
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N0265
CAS No.: 39524-08-8
Synonyms: Akebia saponin D
Asperosaponin VI is a saponin component from Dipsacus asper. Asperosaponin VI induces osteoblast differentiation through the BMP-2/p38 and ERK1/2 signaling pathways. Asperosaponin VI protects against hypoxia-induced cardiomyocyte apoptosis by activating the PI3K/Akt and CREB pathways. Additionally, Asperosaponin VI also has antidepressant and wound-healing-promoting activities [2] .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N0316
CAS No.: 55481-88-4
Mollugin is an orally active and potent NF-κB inhibitor. Mollugin induces S-phase arrest of HepG2 cells, and increased intracellular reactive oxygen species (ROS) levels. Mollugin induces DNA damage in HepG2 cells, as well as an increase in the expression of p-H2AX. Mollugin shows anti-cancer effect by inhibiting TNF-α-induced NF-κB activation. Mollugin enhances the osteogenic action of BMP-2 (bone morphogenetic protein 2) via the p38-Smad signaling pathway [2] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P99590
CAS No.: 1001080-50-7
Synonyms: ACE-011; MK-7962

Target:  

TGF-β Receptor

Sotatercept (ACE-011) is a soluble activin receptor 2A (ACVR2A) type IgG Fc fusion protein. Sotatercept combines activin and growth differentiation factor to try to restore the balance between growth promotion and growth inhibition signal pathways. Sotatercept has potential application in pulmonary arterial hypertension, anemia, bone loss, erythropoiesis, multiple myeloma (MM) osteolytic lesions [2] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P0254
CAS No.: 374675-21-5
Target:  

Kisspeptin Receptor

Domaines de recherche:  

Cardiovascular Disease Cancer

Kisspeptin-10, human is a potent vasoconstrictor and inhibitor of angiogenesis. Kisspeptin-10, human acts as a tumor metastasis suppressor via its receptor GPR54. Kisspeptin-10-GPR54 system plays an important role in embryonic kidney development. Kisspeptin-10/GPR54 signaling induces osteoblast differentiation via NFATc4-mediated BMP2 expression .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-107245
CAS No.: 164991-89-3
Pureté:  99.51%
Segetalin B, an orally active cyclopentapeptide found in Vaccaria segetalis, possesses estrogen-like activity. Segetalin B promotes mineralization of ovariectomized rat-derived bone marrow mesenchymal stem cells (BMSCs) in vitro and increases the level of osteocalcin, BMP-2, ALP, and SIRT1 activity. Segetalin B is promising for research of post-menopausal osteoporosis (PMOP) [2] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P0254A
Target:  

Kisspeptin Receptor

Domaines de recherche:  

Cardiovascular Disease Cancer

Kisspeptin-10, human TFA is a potent vasoconstrictor and inhibitor of angiogenesis. Kisspeptin-10, human TFA acts as a tumor metastasis suppressor via its receptor GPR54. Kisspeptin-10-GPR54 system plays an important role in embryonic kidney development. Kisspeptin-10/GPR54 signaling induces osteoblast differentiation via NFATc4-mediated BMP2 expression .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P72854
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: BDA2; BMP-2; BMP-2A; Bone morphogenetic protein 2a; SSFSC
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-123940
CAS No.: 2247894-32-0
Pureté:  98.93%
Target:  

Wnt AAK1

Domaines de recherche:  

Cancer

SGC-AAK1-1, a chemical probe, is a potent and selective AAK1 (AP2 associated kinase 1) inhibitor with an IC50 of 270 nM and a Ki of 9 nM. SGC-AAK1-1 also potently inhibits BMP2K. SGC-AAK1-1 is used to study Wnt pathway related to AAK1 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N1461
CAS No.: 17238-05-0
Synonyms: (±)-Dihydrodaidzein
Dihydrodaidzein is a dietary phytoestrogen. Dihydrodaidzein possesses functions including antioxidation, inhibition of DNA oxidative damage, regulation of lipid metabolism and maintenance of intestinal flora stability. Dihydrodaidzein induces apoptosis, regulates immune responses, modulates tumor-related factors, activates the Bmp-2 signaling pathway, inhibits NF-κB and MAPK, and exhibits anti-inflammatory activity. Dihydrodaidzein can be used in research related to cancer, cardiovascular diseases, osteoporosis and inflammatory diseases [2] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120179
CAS No.: 1454808-95-7
Pureté:  99.73%
Target:  

AAK1

Domaines de recherche:  

Neurological Disease

LP-922761 is a potent, selective and orally active adapter protein-2 associated kinase 1 (AAK1) inhibitor with IC50s of 4.8 nM and 7.6 nM in enzyme and cell assays, respectively. LP-922761 also inhibits BMP-2-inducible protein kinase (BIKE) with an IC50 of 24 nM. LP-922761 exhibits no significant activity at cyclin G-associated kinase (GAK), opioid, adrenergic α2 or GABAa receptors .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P7006B
Pureté:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuBMP-2; BMP2A; BMP-2A; BMP2
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-N2375
CAS No.: 642-38-6
L-Quebrachitol is a methoxy analog of inositol that can be isolated from plants. L-Quebrachitol has free-radical scavenging, gastroprotection, anti-platelet aggregation and anti-diabetic activity. L-Quebrachitol promotes osteoblastogenesis by uppregulation of BMP-2, runt-related transcription factor-2 (Runx2), MAPK (ERK, JNK, p38α), and Wnt/β-catenin signaling pathway [2] .
loading...
    loading...
Cat. No.: HY-136848
CAS No.: 2088179-99-9
Pureté:  96.09%
Domaines de recherche:  

Cancer

SM1-71 (compound 5) is a potent TAK1 inhibitor, with a Ki of 160 nM, it also can covalently inhibit MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2. SM1-71 can inhibit proliferation of multiple cancer cell lines [2] .
loading...
    loading...
Cat. No.: HY-P5832
CAS No.: 836606-84-9
Target:  

TGF-beta/Smad RUNX

Domaines de recherche:  

Metabolic Disease

BMP2-derived peptide is an osteogenic inducer and BMP receptor ligand. BMP2-derived peptide binds to BMP receptors on the cell surface to form a complex, activates the downstream Smad signaling pathway, and regulates the expression of osteogenic transcription factors. BMP2-derived peptide effectively promotes the adhesion, proliferation, osteogenic differentiation and mineralization of bone marrow mesenchymal stem cells, significantly up-regulates the mRNA levels of OCN, Runx2 and type I collagen, and increases alkaline phosphatase activity and calcium deposition. BMP2-derived peptide induces osteoblast differentiation and ectopic bone regeneration, and improves cranial bone defect repair. Meanwhile, BMP2-derived peptide enhances the cytocompatibility of mesoporous silica nanoparticles, synergistically increases osteogenic activity with Dexamethasone (HY-14648), serving as an important tool for bone defect repair research [2] .
loading...
    loading...